16-19th July 2018 at Weetwood Hall, Leeds, UK.
Confirmed speakers include: Michel Versluis, Eleanor Stride, Maya Thanou, Klazina Kooiman, Helen Mulvana, Mengxing Tang, Alexander Klibanov, Ali Sever, Cryil Lafon, John Hossack, Lori Bridal, Paul Beard, Jeff Bamber and Andrew Healey.
Leeds Microbubble Consortium brings together engineers, physicists, chemists and cancer specialists from across the University to work on the technique of using small gas filled bubbles to deliver anti-cancer drugs directly to a tumour, using ultrasound to image the bubbles as well as promoting delivery of the drug.
1st July 2017 to 30th June 2020. This project addresses several key challenges that need to be resolved to allow the clinical development of MBs as combined therapy and diagnostic agents. In our recent EPSRC Programme we succeeded in building an instrument for the manufacture of MBs... read more >
This project is focused around the research of Microbubbles for Hydrophobic Drug Delivery and Enhanced Diagnostics. This will be used for personalised healthcare for the treatment of Colorectal Cancer, commonly referred to as Bowel Cancer. Professor Steve Evans, University of Leeds, School of Physics and Astronomy is leading the project... read more >
Colorectal Cancer (CRC) is the third most common cancer in the UK, with approximately 32,300 new cases diagnosed and 14,000 deaths in England and Wales each year. Occurrence of colorectal cancer is strongly related to age, with 83% of cases arising in people older than 60 years... read more >